Highlights

  • Enlitic shares rose 18.18% to AUD 0.013 on 12 May 2026 following a deployment update in New Zealand.
  • Ensight has gone live at RHCNZ Medical Imaging Group, New Zealand’s largest private radiology provider.
  • RHCNZ operates more than 65 clinics with over 170 specialist radiologists nationwide.
  • The deployment marks the first production use of Enlitic’s integration with Intelerad’s IntelePACS platform.
  • The update follows record Q1 FY26 contract wins totalling A$5.1 million across 17 agreements.

Enlitic Inc (ASX:ENL) shares surged during the morning session on 12 May 2026 after the artificial intelligence healthcare software company announced a major production deployment of its Ensight platform in New Zealand.

The stock traded at AUD 0.013, up 18.18% for the session, although shares remain down 56.67% over the past 12 months.

Today’s market reaction appeared linked to investor optimism surrounding the company’s continued enterprise expansion, including the first production deployment of its integration with Intelerad’s IntelePACS platform and a new customer rollout involving New Zealand’s largest private radiology provider.

The latest announcement also follows a record Q1 FY26 for contract wins, suggesting growing commercial momentum for the company’s medical imaging software platform.

Enlitic develops artificial intelligence software products used to manage and standardise medical imaging data across radiology workflows. The company’s technology is designed to improve how imaging information such as MRI, CT scan, X-ray and ultrasound data is organised, integrated and analysed within healthcare systems. Enlitic’s product suite aims to support workflow efficiency, data standardisation and imaging interoperability for healthcare providers globally.

Ensight Goes Live at New Zealand’s Largest Private Radiology Provider

The centrepiece of the latest update was the go-live of Enlitic’s Ensight platform at RHCNZ Medical Imaging Group.

RHCNZ is New Zealand’s largest private radiology provider and operates more than 65 clinics nationwide through the Auckland Radiology, Bay Radiology and Pacific Radiology brands.

The group employs more than 1,400 staff and over 170 specialist radiologists while delivering more than 35% of radiology services across New Zealand.

According to Enlitic, the deployment represents the company’s first customer implementation in New Zealand and also marks the first production use of its integration with Intelerad’s IntelePACS system.

The initial deployment phase is focused on hanging protocols, which standardise the way imaging studies are presented to radiologists during the diagnostic review process.

Management said the implementation is intended to improve both reading efficiency and diagnostic consistency across RHCNZ’s nationwide network.

By applying consistent display logic throughout the organisation, the platform aims to streamline radiology workflows and support operational standardisation across multiple clinics and radiologists.

The company also stated that RHCNZ has identified additional potential use cases for Ensight beyond the initial deployment phase, suggesting scope for further platform expansion over time.

Integration With Intelerad Marks Key Commercial Milestone

Another important component of the update involved Enlitic’s integration with Intelerad’s IntelePACS platform.

The deployment represents the first production validation of the integration in a live enterprise environment.

The integration was developed over the past year and enables Ensight to be deployed directly into Intelerad-hosted environments.

Picture archiving and communication systems (PACS) are widely used within healthcare settings to store, retrieve and manage medical imaging data.

Intelerad is considered one of the major providers within this segment, making the successful production deployment potentially significant for Enlitic’s future commercial opportunities.

Management noted that Intelerad is one of eight global OEMs currently engaged with Enlitic’s Migrations and Data Management offering.

The successful deployment at RHCNZ may therefore strengthen Enlitic’s position within the Intelerad ecosystem and provide an operational reference point for future implementations.

Enterprise validation within healthcare environments is often an important commercial milestone for healthcare software companies, particularly where integration into existing infrastructure systems is required.

The ability to demonstrate production-level deployment at scale may support future customer adoption discussions across broader healthcare networks.

Record Q1 FY26 Contract Wins Provide Additional Momentum

The New Zealand deployment follows what the company described as a record Q1 FY26 for contract wins.

During the quarter, Enlitic signed A$5.1 million in total contract value across 17 agreements.

Among the contracts secured were agreements worth US$2.95 million involving Penn Medicine, St. Jude Children’s Research Hospital and Parkland Health.

The company indicated that the RHCNZ deployment aligns with its broader strategy of expanding the installed base of its Ensight platform through both direct enterprise relationships and OEM distribution channels.

The combination of direct customer deployments and channel partnerships appears central to Enlitic’s commercial expansion strategy.

Healthcare imaging remains a large and increasingly data-intensive sector, with hospitals and radiology providers seeking technologies capable of improving efficiency, interoperability and workflow management.

Artificial intelligence and imaging workflow automation technologies have become areas of growing Investment interest as healthcare systems manage increasing imaging volumes and operational pressures.

Enlitic’s focus on imaging data standardisation and workflow optimisation places the company within these broader healthcare digitisation trends.

Management Commentary Highlights Long-Term Opportunity

Chief Executive Officer Michael Sistenich described the RHCNZ deployment as validation of both the Ensight platform and the Intelerad integration within a live production setting.

Management stated that RHCNZ represents the type of enterprise-scale partner Enlitic aims to work with as it expands into additional international markets.

According to the company, hanging protocols represent only the initial phase of integration between the two organisations, with additional potential Ensight applications already identified.

Mr Sistenich also noted that deployment across a radiology network of RHCNZ’s scale provides Enlitic with an important enterprise reference point within the Intelerad channel.

The company further suggested that as Ensight becomes increasingly embedded into customer workflows, the pathway toward recurring software-as-a-service Revenue becomes more visible.

Meanwhile, RHCNZ Chief Digital Officer Shayne Hunter said the deployment supports the group’s objective of improving workflow efficiency and imaging consistency across its network.

Management at RHCNZ also confirmed that additional deployment opportunities may exist beyond the initial hanging protocols implementation.

Healthcare AI and Imaging Software Market Continues Expanding

The latest deployment comes amid continued growth across the healthcare technology and radiology software sectors globally.

Medical imaging providers continue facing rising scan volumes, increasing data complexity and ongoing pressure to improve workflow efficiency.

Artificial intelligence technologies are increasingly being introduced into radiology environments to assist with workflow management, imaging organisation, data standardisation and operational optimisation.

At the same time, healthcare providers are increasingly seeking interoperable systems capable of integrating with existing imaging infrastructure platforms such as PACS systems.

The successful integration of AI-enabled workflow tools into enterprise imaging environments may therefore remain an important competitive Factor within the sector.

Enlitic’s latest deployment suggests the company is continuing to position itself within this evolving healthcare technology landscape through both direct deployments and strategic integration partnerships.

What This Means for Investors?

Enlitic’s latest update highlighted another enterprise deployment milestone for its Ensight imaging platform and reinforced the company’s expansion into international healthcare markets.

The production go-live at New Zealand’s largest private radiology provider, combined with the first live deployment of its Intelerad integration, appeared to be key drivers behind today’s share price movement.

The announcement also followed record quarterly contract wins earlier in FY26, which may have strengthened investor focus on the company’s commercial growth trajectory.

At the operational level, the deployment provides Enlitic with a new reference customer within a large radiology network while potentially supporting future opportunities through OEM and enterprise channels.

Although the company’s shares remain lower over the past year, today’s market reaction suggests investors responded favourably to the latest signs of customer adoption and platform expansion.